Medistim ASA
F:MD1

Watchlist Manager
Medistim ASA Logo
Medistim ASA
F:MD1
Watchlist
Price: 21.6 EUR 1.89% Market Closed
Market Cap: 395.6m EUR

Intrinsic Value

The intrinsic value of one MD1 stock under the Base Case scenario is 16.3 EUR. Compared to the current market price of 21.6 EUR, Medistim ASA is Overvalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MD1 Intrinsic Value
16.3 EUR
Overvaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Medistim ASA

What is Valuation History?
Ask AI Assistant
What other research platforms think about MD1?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MD1 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Medistim ASA.

Explain Valuation
Compare MD1 to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MEDI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medistim ASA

Current Assets 426.3m
Cash & Short-Term Investments 157.7m
Receivables 101.7m
Other Current Assets 166.9m
Non-Current Assets 148.8m
PP&E 69.2m
Intangibles 71.2m
Other Non-Current Assets 8.5m
Current Liabilities 128m
Other Current Liabilities 128m
Non-Current Liabilities 28.6m
Long-Term Debt 21.3m
Other Non-Current Liabilities 7.3m
Efficiency

Free Cash Flow Analysis
Medistim ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medistim ASA

Revenue
668.6m NOK
Cost of Revenue
-125.6m NOK
Gross Profit
543m NOK
Operating Expenses
-363.3m NOK
Operating Income
179.7m NOK
Other Expenses
-37.3m NOK
Net Income
142.4m NOK
Fundamental Scores

MD1 Profitability Score
Profitability Due Diligence

Medistim ASA's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
Exceptional 3Y Average ROE
Exceptional ROE
69/100
Profitability
Score

Medistim ASA's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

MD1 Solvency Score
Solvency Due Diligence

Medistim ASA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
85/100
Solvency
Score

Medistim ASA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MD1 Price Targets Summary
Medistim ASA

Wall Street analysts forecast MD1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MD1 is 22.15 EUR with a low forecast of 16.87 EUR and a high forecast of 28.07 EUR.

Lowest
Price Target
16.87 EUR
22% Downside
Average
Price Target
22.15 EUR
3% Upside
Highest
Price Target
28.07 EUR
30% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MEDI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MD1 stock?

The intrinsic value of one MD1 stock under the Base Case scenario is 16.3 EUR.

Is MD1 stock undervalued or overvalued?

Compared to the current market price of 21.6 EUR, Medistim ASA is Overvalued by 25%.

Back to Top